Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021

W. van Loon, Heike Rössig, S. Burock, J. Hofmann, J. Bernhard, Elisabeth Linzbach, Domenika Pettenkofer, C. Schönfeld, M. Gertler, J. Seybold, T. Kurth, F. Mockenhaupt

Emerging infectious diseases, 2021

Within 5 weeks in 2021, B.1.1.7 became the dominant severe acute respiratory syndrome coronavirus 2 lineage at an outpatient testing site in Berlin, Germany. Compared with outpatients with wild-type virus infection, patients with B.1.1.7 had similar cycle threshold values, more frequent sore throat and travel history, and less frequent anosmia/ageusia.

Cited by 67 publications.

Field of study: Medicine

10.3201/eid2707.210845